FDA Inspection
TTY Biopham Company Ltd (Chung-Li Factory)TTY Biopham Company Ltd (Chung-Li Factory) – FDA Inspection, Nov 16, 2018
Record Details
This FDA Inspection record concerns TTY Biopham Company Ltd (Chung-Li Factory), with an inspection on November 16, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Rita K. Vick (Issuing Officer)
View Company Profile
ID · be2cbaec-5bea-4caa-ab8c-694abd001eef
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1074092
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of TTY Biopham Company Ltd (Chung-Li Factory)
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 2, 2025 | Not classified | Office of Inspections and Investigations | |
| March 18, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for TTY Biopham Company Ltd (Chung-Li Factory)
- FDA Inspection 1271715 - 2025-05-02
- FDA Inspection 965256 - 2016-03-18
- FDA Inspection 851466 - 2013-09-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.